Nasdaq · Common Stock · Pharmaceutical Preparations
Global healthcare company
252 entities across 56 jurisdictions, 20 in offshore financial centres. Read directly from the company’s own 10-K EX-21 filed 2026-02-26 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| Agila Australasia Pty Ltd | Australia | |
| Alphapharm Pty. Ltd. | Australia | |
| Mylan Australia Holding Pty Ltd | Australia | |
| Mylan Australia Pty Limited | Australia | |
| Upjohn Australia Pty Ltd | Australia | |
| Viatris Pty. Ltd. | Australia | |
| Arcana Arzneimittel GmbH | Austria | |
| Viatris Austria GmbH | Austria | |
| Upjohn BV | Belgium | |
| Viatris BV | Belgium | |
| Viatris GX BV | Belgium | |
| Mylan Bermuda Ltd. | Bermuda | offshore centre |
| Viatris Farmaceutica do Brasil Ltda | Brazil | |
| Viatris Brasil Importadora e Distribuidora De Medicamentos Ltda | Brazil | |
| BGP Pharma ULC | Canada | |
| Mylan Pharmaceuticals ULC | Canada | |
| Upjohn Canada ULC | Canada | |
| Ge Zhi (Hainan) Medical Technology Co., Ltd. | China | |
| Viatris (Hainan) Investment Co., Ltd. | China | |
| Viatris Pharmaceutical Co., Ltd. | China | |
| Viatris Pharmaceuticals (Dalian) Co., Ltd. | China | |
| Onco Laboratories Limited | Cyprus | offshore centre |
| Viatris CZ s.r.o. | Czech Republic | |
| Acton Pharmaceuticals, Inc. | Delaware | |
| Alaven Pharmaceutical LLC | Delaware | |
| ALVP Holdings, LLC | Delaware | |
| Delcor Asset Corporation | Delaware | |
| Denco Asset, LLC | Delaware | |
| Deogun Manufacturing, LLC | Delaware | |
| Dey Limited Partner LLC | Delaware | |
| Dey, Inc. | Delaware | |
| EMD, Inc. | Delaware | |
| Ezio Pharma, Inc. | Delaware | |
| Franklin Pharmaceutical LLC | Delaware | |
| Greenstone LLC | Delaware | |
| Madaus Inc. | Delaware | |
| Marquis Industrial Company, LLC | Delaware | |
| Meda Pharmaceuticals Inc. | Delaware | |
| Mylan API Inc. | Delaware | |
| Mylan Consumer Healthcare, Inc. | Delaware | |
| Mylan D.T. (U.S.) Holdings, Inc. | Delaware | |
| Mylan D.T. DPT Partner Sub, LLC | Delaware | |
| Mylan D.T., Inc. | Delaware | |
| Mylan Holdings Inc. | Delaware | |
| Mylan Holdings I LLC | Delaware | |
| Mylan Holdings II LLC | Delaware | |
| Mylan Institutional LLC | Delaware | |
| Mylan Investment Holdings 4 LLC | Delaware | |
| Mylan Investment Holdings 5 LLC | Delaware | |
| Mylan Investment Holdings 6 LLC | Delaware | |
| Mylan Securitization LLC | Delaware | |
| Mylan Special Investments LLC | Delaware | |
| Mylan Special Investments II, LLC | Delaware | |
| Mylan Special Investments III, LLC | Delaware | |
| Mylan Special Investments IV, LLC | Delaware | |
| Mylan Special Investments V, LLC | Delaware | |
| Mylan Special Investments VI, LLC | Delaware | |
| Nimes Inc. | Delaware | |
| Oyster Point Pharma, Inc. | Delaware | |
| Powder Street, LLC | Delaware | |
| Prestium Pharma, Inc. | Delaware | |
| Somerset Pharmaceuticals, Inc. | Delaware | |
| Upjohn US 2 LLC | Delaware | |
| Upjohn US Employment Inc. | Delaware | |
| Upjohn US Holdings Inc. | Delaware | |
| Upjohn Worldwide Holdings Inc. | Delaware | |
| Utah Acquisition Holdco Inc. | Delaware | |
| Utah Acquisition Sub Inc. | Delaware | |
| Viatris Holdco Inc. | Delaware | |
| Viatris Enterprises LLC | Delaware | |
| Viatris Holdings LLC | Delaware | |
| Viatris Overseas Inc. | Delaware | |
| Viatris Pharmaceuticals LLC | Delaware | |
| Viatris Specialty LLC | Delaware | |
| Viatris US Holdings 4 LLC | Delaware | |
| Viatris US Holdings 5 LLC | Delaware | |
| Viatris US Supply Hub LLC | Delaware | |
| Wallace Pharmaceuticals Inc. | Delaware | |
| Mylan ApS | Denmark | |
| Viatris ApS | Denmark | |
| Viatris Egypt Pharmaceutical S.A.E. | Egypt | |
| Viatris Egypt S.A.E. | Egypt | |
| Viatris Health Care | Egypt | |
| Viatris Oy | Finland | |
| Mylan Generics France Holding S.A.S. | France | |
| Mylan Laboratories S.A.S. | France | |
| Viatris Healthcare | France | |
| Viatris Medical | France | |
| Viatris Sante | France | |
| Viatris Up | France | |
| Erste Madaus Beteiligungs GmbH | Germany | |
| Madaus GmbH | Germany | |
| MEDA Germany Holding GmbH | Germany | |
| MEDA Manufacturing GmbH | Germany | |
| MEDA Pharma GmbH & Co. KG | Germany | |
| MWB Pharma GmbH | Germany | |
| Mylan dura GmbH | Germany | |
| Mylan Germany GmbH | Germany | |
| Pharmazeutische Union GmbH | Germany | |
| PharmLog Pharma Logistik GmbH | Germany | |
| ROTTAPHARM | MADAUS GmbH | Germany | |
| VIATRIS GmbH | Germany | |
| Viatris Healthcare GmbH | Germany | |
| Viatris Pharma GmbH | Germany | |
| Zweite Madaus Beteiligungs GmbH | Germany | |
| Mylan (Gibraltar) 4 Limited | Gibraltar | offshore centre |
| Mylan (Gibraltar) 5 Limited | Gibraltar | offshore centre |
| Mylan (Gibraltar) 6 Limited | Gibraltar | offshore centre |
| Mylan (Gibraltar) 7 Limited | Gibraltar | offshore centre |
| Mylan (Gibraltar) 8 Limited | Gibraltar | offshore centre |
| Mylan (Gibraltar) 9 Limited | Gibraltar | offshore centre |
| Viatris Hellas Limited Liability Company | Greece | |
| Mylan Pharmaceutical Hong Kong Limited | Hong Kong | |
| Viatris Healthcare Hong Kong Limited | Hong Kong | |
| Mylan Hungary Kft. | Hungary | |
| Viatris Healthcare Kft. | Hungary | |
| Viatris Services Kft. | Hungary | |
| Mylan Institutional Inc. | Illinois | |
| Famy Life Sciences Private Limited | India | |
| Mylan Laboratories Limited | India | |
| Mylan Pharmaceuticals Private Limited | India | |
| McDermott Laboratories Limited | Ireland | |
| Meda Health Sales Ireland Limited | Ireland | |
| Mylan Investments Limited | Ireland | |
| Mylan IRE Healthcare Limited | Ireland | |
| Mylan Ireland Investment Designated Activity Company | Ireland | |
| Mylan Ireland Limited | Ireland | |
| Mylan Pharma Acquisition Limited | Ireland | |
| Mylan Pharma Group Limited | Ireland | |
| Mylan Pharma Holdings Limited | Ireland | |
| Mylan Pharmaceuticals Limited | Ireland | |
| Mylan Teoranta | Ireland | |
| Rottapharm Limited | Ireland | |
| Upjohn Manufacturing Ireland Unlimited | Ireland | |
| Viatris Healthcare Limited | Ireland | |
| Viatris Limited | Ireland | |
| Mylan S.p.A. | Italy | |
| Viatris Italia S.r.l. | Italy | |
| Viatris Pharma S.r.l. | Italy | |
| Aculys Pharma, Inc. | Japan | |
| Mylan Seiyaku Ltd. | Japan | |
| Viatris Healthcare G.K | Japan | |
| Viatris Pharmaceuticals Japan G.K. | Japan | |
| BGP Products S.à r.l. | Luxembourg | offshore centre |
| Integral S.A. | Luxembourg | offshore centre |
| Meda Pharma S.à r.l. | Luxembourg | offshore centre |
| Mylan Luxembourg 1 S.à r.l. | Luxembourg | offshore centre |
| Mylan Luxembourg 2 S.à r.l. | Luxembourg | offshore centre |
| Mylan Luxembourg 3 S.à r.l. | Luxembourg | offshore centre |
| Mylan Luxembourg 6 S.à r.l. | Luxembourg | offshore centre |
| Mylan Luxembourg 7 S.à r.l. | Luxembourg | offshore centre |
| Mylan Luxembourg S.à r.l. | Luxembourg | offshore centre |
| SIM S.A. | Luxembourg | offshore centre |
| VI Lux Newco S.à r.l. | Luxembourg | offshore centre |
| Mylan Healthcare Sdn. Bhd. | Malaysia | |
| Pfizer Parke Davis Sdn. Bhd. | Malaysia | |
| Viatris Sdn. Bhd. | Malaysia | |
| MP Laboratories (Mauritius) Ltd. | Mauritius | offshore centre |
| Meda Phama, S. de R.L. de C.V. | Mexico | |
| Meda Pharma Servicios, S. de R.L. de C.V. | Mexico | |
| Viatris Healthcare Mexico S. de R.L. de C.V. | Mexico | |
| Viatris Pharmaceuticals S.A.S. | Morocco | |
| Meda Pharma B.V. | Netherlands | |
| Mylan B.V. | Netherlands | |
| Mylan Group B.V. | Netherlands | |
| Mylan II B.V. | Netherlands | |
| Upjohn Belgium B.V. | Netherlands | |
| Upjohn EESV | Netherlands | |
| Upjohn Europe Holdings B.V. | Netherlands | |
| Upjohn Export B.V. | Netherlands | |
| Upjohn Finance B.V. | Netherlands | |
| Upjohn Global Holdings B.V. | Netherlands | |
| Upjohn Group Holdings B.V. | Netherlands | |
| Upjohn International Holdings B.V. | Netherlands | |
| Upjohn Vietnam Dutch B.V. | Netherlands | |
| Viatris Enterprise Holding B.V. | Netherlands | |
| Viatris Healthcare B.V. | Netherlands | |
| Viatris Ireland Holding B.V. | Netherlands | |
| Viatris Manufacturing B.V. | Netherlands | |
| Viatris Mexico Holding B.V. | Netherlands | |
| Viatris Netherlands B.V. | Netherlands | |
| Viatris Philippines Holding B.V. | Netherlands | |
| Viatris Turkey Holding B.V. | Netherlands | |
| FamyGen Life Sciences, Inc. | Nevada | |
| Agila Specialties Inc. | New Jersey | |
| Viatris Pharmaceuticals Pty Ltd | Nigeria | |
| Mylan Health Management LLC | North Carolina | |
| Viatris AS | Norway | |
| ZpearPoint AS | Norway | |
| MLRE LLC | Pennsylvania | |
| Mylan Holdings Sub Inc. | Pennsylvania | |
| Mylan Inc. | Pennsylvania | |
| Synerx Pharma, LLC | Pennsylvania | |
| Viatris, Inc. | Philippines | |
| Viatris Pharmaceuticals, Inc. | Philippines | |
| Viatris Healthcare spółka z o.o. | Poland | |
| Viatris Trade sp. z o.o. | Poland | |
| BGP Products, Unipessoal, LDA | Portugal | |
| Laboratorios Anova - Produtos Farmaceuticos, LDA | Portugal | |
| Laboratorios Delta, S.A. | Portugal | |
| Mylan, Lda | Portugal | |
| Viatris Healthcare, Lda. | Portugal | |
| BGP Products S.r.l. | Romania | |
| Viatris Arabia Limited “LLC” | Saudi Arabia | |
| Viatris Arabia Regional Headquarters | Saudi Arabia | |
| Mylan Pharmaceuticals Pte. Ltd. | Singapore | |
| Viatris Asia Pacific Pte Ltd. | Singapore | |
| Viatris Private Limited | Singapore | |
| Viatris Singapore Pte Ltd. | Singapore | |
| Meda Pharma South Africa (Pty) Limited | South Africa | |
| Mylan Pharmaceuticals (Pty) Ltd. | South Africa | |
| SCP Pharmaceuticals (Proprietary) Limited | South Africa | |
| Upjohn South Africa Proprietary Limited | South Africa | |
| Viatris Healthcare (Pty) Ltd | South Africa | |
| Viatris South Africa (Proprietary) Limited | South Africa | |
| Viatris Korea | South Korea | |
| Fundacion Viatris para la Salud | Spain | |
| Meda Pharma, S.L. | Spain | |
| Viatris Pharmaceuticals, S.L. | Spain | |
| Abbex AB | Sweden | |
| BGP Products AB | Sweden | |
| Ipex AB | Sweden | |
| Ipex Medical AB | Sweden | |
| Meda AB | Sweden | |
| Meda OTC AB | Sweden | |
| Mylan AB | Sweden | |
| Mylan Sweden Holdings AB | Sweden | |
| Recip AB | Sweden | |
| Scandinavian Pharmaceuticals-Generics AB | Sweden | |
| Viatris AB | Sweden | |
| BGP Products Operations GmbH | Switzerland | |
| MEDA Pharma GmbH | Switzerland | |
| MEDA Pharmaceuticals Switzerland GmbH | Switzerland | |
| Mylan Holdings GmbH | Switzerland | |
| Mylan (Taiwan) Limited | Taiwan | |
| Viatris Pharmaceutical Company Limited | Taiwan | |
| DPT Laboratories, Ltd. | Texas | |
| Mylan Bertek Pharmaceuticals Inc. | Texas | |
| Viatris Healthcare (Thailand) Limited | Thailand | |
| Viatris Pharmaceuticals (Thailand) Limited | Thailand | |
| Viatris (Thailand) Limited | Thailand | |
| Viatris Ilaclari Limited Sirketi | Turkey | |
| Meda Pharmaceuticals MEA FZ-LLC | United Arab Emirates | |
| Mylan FZ-LLC | United Arab Emirates | |
| Viatris Middle East FZ-LLC | United Arab Emirates | |
| American Triumvirate Insurance Company | Vermont | |
| Mylan International Holdings, Inc. | Vermont | |
| Viatris Vietnam Limited Company | Vietnam | |
| MP AIR, Inc. | West Virginia | |
| Mylan Pharmaceuticals Inc. | West Virginia | |
| Mylan Technologies, Inc. | West Virginia | |
| Mylan ASI LLC | Wyoming |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $11.9B | −$669.9M | $988.8M | 31.8% | 601,200,000 |
| FY2021 | $17.9B | −$1.3B | $2.6B | 31.2% | 1,208,800,000 |
| FY2022 | $16.3B | $2.1B | $2.5B | 40.0% | 1,217,400,000 |
| FY2023 | $15.4B | $54.7M | $2.4B | 41.7% | 1,206,900,000 |
| FY2024 | $14.7B | −$634.2M | $2.0B | 38.2% | — |
| FY2025 | $14.3B | −$3.5B | $1.9B | 35.1% | — |
14 institutions tracked — 8 added, 4 reduced, 2 opened a new position.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| FMR LLC | Active fund | 96,662,102 | +80,073,588 | $1.5B |
| CITADEL ADVISORS LLC | Hedge fund | 1,405,059 | −3,937,096 | $22.3M |
| PRICE T ROWE ASSOCIATES INC /MD/ | Active fund | 68,214,436 | +2,350,332 | $1.1B |
| BlackRock, Inc. | Index | 86,019,468 | +1,659,664 | $1.4B |
| AQR CAPITAL MANAGEMENT LLC | Hedge fund | 4,694,966 | −1,646,352 | $74.6M |
| JPMORGAN CHASE & CO | Active fund | 7,322,267 | +1,590,702 | $119.7M |
| Point72 Asset Management, L.P. | Hedge fund | 622,629 | −1,154,552 | $9.9M |
| Bridgewater Associates, LP | Hedge fund | 1,698,341 | +972,457 | $27.0M |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 32,807,906 | +961,799 | $520.1M |
| MORGAN STANLEY | Active fund | 15,128,899 | −961,040 | $240.2M |
| STATE STREET CORP | Index | 53,069,461 | +835,762 | $842.7M |
| BANK OF AMERICA CORP /DE/ | Active fund | 7,356,708 | +97,153 | $116.8M |
NORGES BANK, WELLINGTON MANAGEMENT GROUP LLP hold a position with no prior filing to compare against, so their change is unknown rather than zero — and they are left out of the totals above.
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
What the company actually paid out and bought back, as reported — the record behind any yield figure.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
Viatris Inc files under SIC 2834 — all 50 pharmaceutical preparations companies compared on assets and F-score.
Where dealer gamma sat in VTRS’s option chain after the close on 2026-09-01, aggregated from the full chain. This is a once-a-day snapshot, not a live read — 89 contracts.
Computed from the listed option chain by my own aggregation, once, after the close — it describes where positioning sat that evening and does not update through the next session. The version that rebuilds per strike while the market is open is the intraday gamma product. Not investment advice.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.